PEDIATRICS Vol. 42 No. 2 August 1968, pp. 371-372
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cornblath, M.
Right arrow Articles by Drash, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cornblath, M.
Right arrow Articles by Drash, A.

Letters to the Editor

Marvin Cornblath M.D.1 and Allan Drash M.D.2

1 Department of Pediatrics, University of Illinois, College of Medicine, Chicago, Illinois
2 Department of Pediatrics, University of Illinois, College of Medicine, Chicago, Illinois

In reply to Dr. Ehrlich's questions, we only wish that life would be as simple as he implied. The association of increased peripheral venous insulin values with islet cell adenoma is by no means universal in adults. In a child with multiple islet cell adenomata (Pediatrics, 39:59, 1967) , fasting plasma insulins as well as those following glucose, tolbutamide, and leucine, were not abnormally elevated. No other studies of peripheral or portal plasma insulin levels in infants or children with islet cell adenoma are known to us.